David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 200,000 shares at $0.40 ($79K) on 2014-11-11, disclosed to the SEC on 2014-11-12.
Open-market purchase of $79k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.39 | 16,605 | $6K | 8.2% |
| 2 | $0.39 | 32,707 | $13K | 16.2% |
| 3 | $0.40 | 33,395 | $13K | 17.0% |
| 4 | $0.40 | 67,293 | $27K | 34.3% |
| 5 | $0.38 | 50,000 | $19K | 24.2% |
| Total | $0.39 avg | 200,000 |
| $79K |
| 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |